review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00115-016-0146-5 |
P698 | PubMed publication ID | 27337987 |
P50 | author | Frank Schneider | Q1430644 |
P2093 | author name string | W Hewer | |
P2860 | cites work | Clinical practice guideline on diagnosis and treatment of hyponatraemia | Q22241512 |
Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy | Q23009758 | ||
Cancer care for individuals with schizophrenia | Q27009111 | ||
The diagnosis of chronic obstructive pulmonary disease | Q27026678 | ||
Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis | Q28082390 | ||
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Q30836810 | ||
Associations between chronic diseases and choking deaths among older adults in the USA: a cross-sectional study using multiple cause mortality data from 2009 to 2013. | Q31022486 | ||
Assessing QT interval prolongation and its associated risks with antipsychotics. | Q33160123 | ||
Hyponatremia: differential diagnosis and therapy | Q33164946 | ||
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. | Q33814201 | ||
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). | Q34018491 | ||
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34351265 | ||
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis | Q34507164 | ||
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. | Q34623350 | ||
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. | Q35016170 | ||
A Surveillance System to Monitor Excess Mortality of People With Mental Illness in Canada | Q36371835 | ||
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review | Q36377890 | ||
The Prevalence and Incidence of Diabetes in Germany | Q36850643 | ||
Physical illness and schizophrenia: a review of the literature | Q36962153 | ||
Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries | Q37677373 | ||
Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis | Q38064833 | ||
Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients | Q38139841 | ||
Excess early mortality in schizophrenia | Q38169215 | ||
The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis | Q38783318 | ||
Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study | Q40639608 | ||
How many people in Germany are seriously mentally ill? | Q41147296 | ||
Thirty-Day Mortality After Infection Among Persons With Severe Mental Illness: A Population-Based Cohort Study in Denmark | Q41386085 | ||
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia | Q44299748 | ||
Assessment of cardiovascular disease risk in patients with schizophrenia spectrum disorders in German psychiatric hospitals: results of the pharmacoepidemiologic CATS study | Q45632870 | ||
Cancer-related mortality in people with mental illness | Q46181379 | ||
Schizophrenia: a life-shortening disease | Q50144024 | ||
Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia. | Q50553203 | ||
Long-term mortality of persons with severe mental illness and diabetes: a population-based cohort study in Denmark. | Q50562102 | ||
Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. | Q50595455 | ||
Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. | Q51903646 | ||
[Primary and secondary prevention of stroke]. | Q53662094 | ||
Diagnostik der systolischen und diastolischen Herzinsuffizienz | Q57399065 | ||
Excess mortality of mental disorder | Q77670488 | ||
[How much general medical competency does a psychiatrist need?] | Q81442160 | ||
[Medical disorders in psychiatric patients] | Q84077502 | ||
[Medical disorders in psychiatric patients] | Q84311774 | ||
Serotonin syndrome in a patient with chronic pain polypharmacy | Q84878166 | ||
[Cardiac and metabolic risk factors in severe mental disorders. Task of a prevention manager] | Q86538328 | ||
[Diastolic heart failure and multimorbidity] | Q86936403 | ||
[Treatment of chronic heart failure: what's not (yet) in the guidelines] | Q86936408 | ||
[Chronic obstructive pulmonary disease (COPD). Current concepts and new therapeutic options] | Q87373841 | ||
[Holistic therapy of chronic heart failure] | Q87829736 | ||
P433 | issue | 7 | |
P304 | page(s) | 787-801 | |
P577 | publication date | 2016-07-01 | |
P1433 | published in | Der Nervenarzt | Q15446312 |
P1476 | title | [Somatic morbidity in the mentally ill] | |
P478 | volume | 87 |